CD28 and Miyoshi myopathy: The latter mechanism, in particular, partially relies on the induction of CD28 signaling in MM cells by DCs, which reduces the capability of MM cells to present antigens through class-I HLA, thus evading CTL recognition through T cell receptor engagement.